|1.||Evers, S: 4 articles (09/2009 - 02/2002)|
|2.||Gracia-Naya, M: 3 articles (03/2012 - 12/2005)|
|3.||Zhang, Yan: 3 articles (08/2011 - 01/2009)|
|4.||Jackson, Jeffrey L: 2 articles (01/2015 - 03/2013)|
|5.||Sobaniec, Wojciech: 2 articles (01/2013 - 01/2004)|
|6.||Mauri-Llerda, J A: 2 articles (03/2012 - 09/2009)|
|7.||Santos-Lasaosa, S: 2 articles (03/2012 - 09/2009)|
|8.||Wan, Qi: 2 articles (09/2011 - 01/2011)|
|9.||Wang, Qiang: 2 articles (09/2011 - 01/2011)|
|10.||Ye, Qing: 2 articles (09/2011 - 01/2011)|
|1.||Migraine Disorders (Migraine)
01/01/1990 - "The results showed remarkable efficacy of long-term prophylaxis with flunarizine, and the response was better in younger patients with a short history of migraine."
06/01/2009 - "There is no significant difference in improving the physical and psychological health of the migraine patients between acupuncture and Flunarizine Hydrochloride, and acupuncture is more effective in reducing the migraine attack days."
01/01/1986 - "Since flunarizine seems to be effective in migraine prevention it may exert a beneficial influence on rCBF in migraine as well. "
01/01/1999 - "For migraine prophylaxis, only flunarizine 5 mg/day has been shown to be effective in more than 1 double-blind, placebo-controlled trial. "
11/01/2014 - "Preventive treatment of behavioral therapy plus oral flunarizine shows a better clinical efficacy than oral flunarizine alone in children with migraine and holds promise for clinical application."
05/01/1989 - "Monitoring serum Flunarizine levels showed no significant difference between patients having improved seizure control and those who were unimproved. "
10/01/1986 - "During treatment with flunarizine we observed the following: 7 cases--no effect on number or severity of seizures; 2 cases--moderate results; 5 cases--good results."
04/01/1984 - "In a therapy-resistant epileptic population with partial complex seizures with or without secondary generalization, addition of flunarizine to existing therapy was accompanied by a significant reduction in complex partial and tonic-clonic seizures. "
01/01/1995 - "On the initial maintenance flunarizine dose, seizure control was improved, with an average seizure reduction of 47% compared to pre-blinded-phase baseline. "
01/01/1992 - "Flunarizine also decreased the severity of behavioral seizures, with 40% of the animals displaying Stage 1-2 seizures only. "
05/01/1985 - "There was a significant reduction in Headache Unit Index (HUI) and Headache Unit Index Corrected (HUIC) (42% and 40.5% respectively) in the flunarizine-treated group but not in the placebo group. "
05/01/1985 - "Children treated with flunarizine experienced a statistically significant reduction in headache (66%) and duration (51%). "
06/01/1992 - "Flunarizine is effective in prophylaxis of headache associated with scleroderma."
01/15/1987 - "Based on the positive results of these studies, we liked to investigate the efficiency and tolerability of Flunarizine also in a sample on n = 44 adults Austrian patients recruited from the Headache-Ambulance of the Neurological Department, University of Vienna. "
05/01/1985 - "Efficacy of flunarizine versus placebo was assessed on the basis of the reduction of headache frequency and duration. "
04/01/2011 - "It is therefore, we conclude that further experimental studies and multicenter clinical trials involving large sample size are needed to establish flunarizine as add-on therapy in refractory epilepsy."
04/01/2011 - "We conducted a PTZ model experimental study to re-evaluate the potential of flunarizine for add-on therapy in the management of refractory epilepsy. "
02/01/2004 - "The present study will summarize our findings concerning the anticonvulsant properties of the Ca2+ channel blocker flunarizine in a variety of experimental models of epilepsy. "
09/01/1995 - "Fourteen ambulatory children and adolescents with intractable epilepsy were studied in an open phase II study to investigate the pharmacokinetics and pharmacodynamics of flunarizine as an add-on treatment. "
07/01/1991 - "Double-blind placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy."
03/01/1983 - "Flunarizine given orally at doses of 20 mg/kg and 10 mg/kg 5 hr before mild hypoxia and at doses of 40 mg/kg and 10 mg/kg 5 hr before severe hypoxia, led to a significant reduction of ischaemic and severe cell change. "
01/01/1988 - "Flunarizine is particularly effective in the cerebral blood vessels, also when they are hyperreactive because of hypoxia. "
04/01/1992 - "Changes in rat striatum catecholamine during hypoxia with reference to protective effects of flunarizine."
12/01/1993 - "While cyclodextrin normalized hypoxia-induced effects in DA release, flunarizine prevented those in DA uptake and improved avoidance learning."
05/01/1985 - "Therefore, a study was made to show whether flunarizine affected hypoxia-induced alterations in synaptic function in slices of hippocampus held in vitro. "
|5.||Calcium Channels (Calcium Channel)
|7.||Valproic Acid (Valproate, Semisodium)
|1.||Artificial Respiration (Mechanical Ventilation)
|2.||Drug Therapy (Chemotherapy)